Complement 3 is involved in changing the phenotype of human glomerular mesangial cells

Journal of Cellular Physiology

Volumn 213, Issue 2, 2007, Pages 495-501

  Wan, Jian Xin ^a   Fukuda, Noboru ^a,b   Endo, Morito ^a,c   Tahira, Yoshiko ^a   Yao, En Hui ^a   Matsuda, Hiroyuki ^a,b   Ueno, Takahiro ^a   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c Hachinohe University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALDESMON; CELL DNA; COLLAGEN TYPE 4; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; GAMMA INTERFERON; MESSENGER RNA; OSTEOPONTIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; COLLAGEN SYNTHESIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DNA SYNTHESIS; GLOMERULOPATHY; HUMAN; HUMAN CELL; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; COMPLEMENT C3; COMPLEMENT C3A; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; MESANGIAL CELLS; PHENOTYPE; RECEPTORS, COMPLEMENT; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34848878632     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21129     Document Type: Article

References (34)

1. Bakris GL, Palant CE, Walsh MF, Sowers JR. 1996. Analogy between endothelial/mesangial cell and endotheial/vascular smooth muscle cell interactions: Role of growth factors and mechanotransduction. In: Sowers JR, editor. Endocrinology of the vasculature. Totowa, NJ: Humana Press. pp 341-355.
2. Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, Lichtman AH. 2002. Influence of C3 deficiency on atherosclerosis. Circulation 105:3025-3031.
3. Daha MR, van Kooten C. 2000. Is there a role for locally produced complement in renal disease? Nephrol Dial Transplant 15:1506-1509.
4. Di Renzo L, Longo A, Morgante E, Mardente S, Prodinger WM, Russo M, Pontieri GM, Lipari M. 1999. C3 molecules internalize and enhance the growth of Lewis lung carcinoma cells. Immunobiology 200:92-105.
5. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ. 1992. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309.
6. Glukhova MA, Frid MG, Koteliansky VE. 1990. Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J Biol Chem 265:13042-13046.
7. Grone EF, Walli AK, Grone HJ, Miller B, Seidel D. 1994. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 107:1-13.
8. Hong MH, Jin CH, Sato T, Ishimi Y, Abe E, Suda T. 1991. Transcriptional regulation of the production of the third component of complement (C3) by 1α, 25-dihydroxyvitamin D3 in mouse marrow-derived stromal cells (ST2) and primary osteoblastic cells. Endocrinology 129:2774-2779.
9. Johnson RJ. 1997. Involvement of complement components in renal disease. Curr Opin Nephrol Hypertens 6:120-127.
10. Laufer J, Katz Y, Passwell JH. 2001. Extrahepatic synthesis of complement proteins in inflammation. Mol Immunol 38:221-229.
11. Li W, Tada T, Miwa T, Okada N, Ito J, Okada H, Tateyama H, Eimoto T. 1999. mRNA expression of complement components and regulators in rat arterial smooth muscle cells. Microbiol Immunol 43:585-593.
12. Lin ZH, Fukuda N, Jin XQ, Yao EH, Ueno T, Endo M, Saito S, Matsumoto K, Mugishima H. 2004. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 44:42-47.
13. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Shikata K, Nagai R, Ota Z. 1995. Phenotypic changes of the mesangium in diabetic nephropathy. J Diabetes Complications 9:282-284.
14. Marston SB, Redwood CS. 1993. The essential role of tropomyosin in cooperative regulation of smooth muscle thin filament activity by caldesmon. J Biol Chem 268:12317-12320.
15. Morgan BP, Gasque P. 1997. Extrahepatic complement biosynthesis: Where, when and why. Clin Exp Immunol 107:1-7.
16. Mosse PR, Campbell GR, Wang ZL, Campbell JH. 1985. Smooth muscle phenotypic expression in human carotid arteries. I: Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 53:556-562.
17. Oda H, Keane WF. 1999. Recent advances in statins and the kidney. Kidney Int 56:S2-S5.
18. Pesce CM, Striker LJ, Peten E, Elliot SJ, Striker GE. 1991. Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605.
19. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for 1990s. Nature 362:801-809.
20. Sacks SH, Zhou W, Andrews PA, Hardley B. 1993a. Endogenous complement C3 synthesis in immune complex nephritis. Lancet 342:1273-1274.
21. Sacks S, Zhou W, Campbell RD, Martin J. 1993b. C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 93:411-417.
22. Schlondorff D. 1987. The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1:272-281.
23. Schwartz SM. 1997. Perspectives series: Cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 99:2814-2816.
24. Seifert PS, Kazatchkine MD. 1988. The complement system in atherosclerosis. Atherosclerosis 73:91-104.
25. Setty S, Kim Y, Fields GB, Clegg DO, Wayner EA, Tsilibary EC. 1998. Interactions of type IV collagen and its domains with human mesangial cells. J Biol Chem 273:12244-12249.
26. Shanahan CM, Weissberg PL, Metcalfe JC. 1993. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73:93-204.
27. Sobue K, Takahashi K, Wakabayashi I. 1985. Caldesmon 150 regulates the tropomyosin-enhanced actin-myosin interaction in gizzard smooth muscle. Biochem Biophys Res Commun 132:645-651.
28. Stockand JD, Sansom SC. 1998. Glomerular mesangial cells: Electro physiology and regulation of contraction. Physiol Rev 78:723-744.
29. Ueki N, Sobue K, Kanda K, Hada T, Higashino K. 1987. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 84:9049-9053.
30. van den Dobbelsteen ME, Verhasselt V, Kaashoek JG, Timmerman JJ, Schroeijers WE, Verweij CL, van der Woude FJ, van Es LA, Daha MR. 1994. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin Exp Immunol 95:173-180.
31. Volanakis JE. 1995. Transcriptional regulation of complement genes. Annu Rev Immunol 13:277-305.
32. Welch TR. 2001. The complement system in renal diseases. Nephron 88:199-204.
33. Welch TR, Beischel LS, Witte DP. 1993. Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 92:1451-1458.
34. Zhou W, Marsh JE, Sacks SH. 2001. Intrarenal synthesis of complement. Kidney Int 59:1227-1235.